Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Fesoterodine Flexible Dose Study

ClinicalTrials.gov ID: NCT00536484

Public ClinicalTrials.gov record NCT00536484. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 5:35 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A 12-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Trial To Evaluate The Efficacy And Safety Of A Fesoterodine Flexible Dose Regimen In Patients With Overactive Bladder.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This Phase 3B study is designed to test if a fesoterodine flexible dose regimen is more effective than placebo in reducing micturition frequency and other overactive bladder (OAB) symptoms, e.g., urgency, urgency incontinence episodes in patients with overactive bladder and if the fesoterodine regimen is safe and well tolerated.

Study identification

NCT ID
NCT00536484
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Pfizer
Industry
Enrollment
896 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 2007 (Type not available)
Primary completion
Mar 2008 (Actual)
Completion
Mar 2008 (Actual)
Last update posted
Sep 15, 2009

2007 – 2008

United States locations

U.S. sites
95
U.S. states
31
U.S. cities
84
Facility City State ZIP Site status
Pfizer Investigational Site Mobile Alabama 36608 —
Pfizer Investigational Site Chandler Arizona 85225 —
Pfizer Investigational Site Peoria Arizona 85381 —
Pfizer Investigational Site Tucson Arizona 85741 —
Pfizer Investigational Site Rancho Cordova California 95670 —
Pfizer Investigational Site Sacramento California 95825 —
Pfizer Investigational Site San Diego California 92103 —
Pfizer Investigational Site Denver Colorado 80210 —
Pfizer Investigational Site Denver Colorado 80211 —
Pfizer Investigational Site Denver Colorado 80218 —
Pfizer Investigational Site Englewood Colorado 80112 —
Pfizer Investigational Site New Britain Connecticut 06052 —
Pfizer Investigational Site Aventura Florida 33180 —
Pfizer Investigational Site Bonita Springs Florida 34134 —
Pfizer Investigational Site Hollywood Florida 33021 —
Pfizer Investigational Site Lake Worth Florida 33461 —
Pfizer Investigational Site Miami Florida 33143 —
Pfizer Investigational Site Miami Florida 33176 —
Pfizer Investigational Site Naples Florida 34102 —
Pfizer Investigational Site Pembroke Pines Florida 33024 —
Pfizer Investigational Site St. Petersburg Florida 33709 —
Pfizer Investigational Site Stuart Florida 34996 —
Pfizer Investigational Site Tallahassee Florida 32308 —
Pfizer Investigational Site Chicago Illinois 60610 —
Pfizer Investigational Site Evansville Indiana 47713 —
Pfizer Investigational Site Jeffersonville Indiana 47130 —
Pfizer Investigational Site Newburgh Indiana 47630 —
Pfizer Investigational Site Iowa City Iowa 52242 —
Pfizer Investigational Site Overland Park Kansas 66210 —
Pfizer Investigational Site Overland Park Kansas 66215 —
Pfizer Investigational Site Pratt Kansas 67124 —
Pfizer Investigational Site Lexington Kentucky 40509 —
Pfizer Investigational Site Louisville Kentucky 40207 —
Pfizer Investigational Site Louisville Kentucky 40291 —
Pfizer Investigational Site Madisonville Kentucky 42431 —
Pfizer Investigational Site Baltimore Maryland 21204 —
Pfizer Investigational Site Bel Air Maryland 21014 —
Pfizer Investigational Site Milford Massachusetts 01757 —
Pfizer Investigational Site Springfield Massachusetts 01103 —
Pfizer Investigational Site West Yarmouth Massachusetts 02673 —
Pfizer Investigational Site Ann Arbor Michigan 48103 —
Pfizer Investigational Site Paw Paw Michigan 49079 —
Pfizer Investigational Site Royal Oak Michigan 48073 —
Pfizer Investigational Site Troy Michigan 48098 —
Pfizer Investigational Site Picayune Mississippi 39466 —
Pfizer Investigational Site St Louis Missouri 63117 —
Pfizer Investigational Site Lincoln Nebraska 68506 —
Pfizer Investigational Site Lincoln Nebraska 68510 —
Pfizer Investigational Site Omaha Nebraska 68114 —
Pfizer Investigational Site Las Vegas Nevada 89104 —
Pfizer Investigational Site Las Vegas Nevada 89130 —
Pfizer Investigational Site New Brunswick New Jersey 08901 —
Pfizer Investigational Site Garden City New York 11530 —
Pfizer Investigational Site Kingston New York 12401 —
Pfizer Investigational Site Manlius New York 13104 —
Pfizer Investigational Site New York New York 10016 —
Pfizer Investigational Site Poughkeepsie New York 12601 —
Pfizer Investigational Site Rochester New York 14609 —
Pfizer Investigational Site Syracuse New York 13210 —
Pfizer Investigational Site Williamsville New York 14221 —
Pfizer Investigational Site Cary North Carolina 27518 —
Pfizer Investigational Site Charlotte North Carolina 28204 —
Pfizer Investigational Site Charlotte North Carolina 28207 —
Pfizer Investigational Site Raleigh North Carolina 27609 —
Pfizer Investigational Site Winston-Salem North Carolina 27103 —
Pfizer Investigational Site Cincinnati Ohio 45212 —
Pfizer Investigational Site Cincinnati Ohio 45249 —
Pfizer Investigational Site Bethany Oklahoma 73008 —
Pfizer Investigational Site Norman Oklahoma 73071 —
Pfizer Investigational Site Portland Oregon 97239 —
Pfizer Investigational Site Lansdale Pennsylvania 19446 —
Pfizer Investigational Site Philadelphia Pennsylvania 19114 —
Pfizer Investigational Site Philadelphia Pennsylvania 19115 —
Pfizer Investigational Site Sellersville Pennsylvania 18960 —
Pfizer Investigational Site State College Pennsylvania 16801 —
Pfizer Investigational Site Cranston Rhode Island 02920 —
Pfizer Investigational Site Cumberland Rhode Island 02864 —
Pfizer Investigational Site Warwick Rhode Island 02886 —
Pfizer Investigational Site Mt. Pleasant South Carolina 29464 —
Pfizer Investigational Site Bristol Tennessee 37620 —
Pfizer Investigational Site Johnson City Tennessee 36701 —
Pfizer Investigational Site Johnson City Tennessee 37601 —
Pfizer Investigational Site Nashville Tennessee 37203 —
Pfizer Investigational Site New Tazewell Tennessee 37825 —
Pfizer Investigational Site Bryan Texas 77802 —
Pfizer Investigational Site Corpus Christi Texas 78414 —
Pfizer Investigational Site Dallas Texas 75231 —
Pfizer Investigational Site Houston Texas 77079 —
Pfizer Investigational Site Longview Texas 75605 —
Pfizer Investigational Site San Antonio Texas 78229 —
Pfizer Investigational Site Arlington Virginia 22205 —
Pfizer Investigational Site Norfolk Virginia 23502 —
Pfizer Investigational Site Richmond Virginia 23294 —
Pfizer Investigational Site Mountlake Terrace Washington 98043 —
Pfizer Investigational Site Spokane Washington 99207 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00536484, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 15, 2009 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00536484 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →